Senior Director Global Regulatory Lead (Early Phase) - Oncology
Eli Lilly and CompanySalary not specified
- Full Time
- Senior (5 to 8 years)
Gilead Sciences
Senior Business Unit Director (m/f/d) Solid Tumors, Breast Cancer
$200,000 – $300,000Compensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
InternshipJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries
Requirements
Candidates should possess a relevant degree and demonstrate experience in leading cross-functional teams, developing commercial strategies, and driving business objectives.
Responsibilities
The Senior Business Unit Director will lead and manage the Oncology business unit, providing vision and coaching to the team, driving the commercial strategy and action plans, overseeing marketing and sales efforts, establishing relationships with key stakeholders, partnering with Medical Affairs and Government Affairs, and ensuring effective infrastructure development to meet business goals.
Skills
Commercial Strategy
Cross-functional Teams
Leadership
Business Objectives
Stakeholder Management
Marketing
Sales
Partnership
Infrastructure Development
Gilead Sciences
Develops and commercializes biopharmaceuticals
About Gilead Sciences
Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.
Key Metrics
Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees